|
Sign In to gain access to subscriptions and/or personal tools.
|
Delirium in advanced cancer patients
Carlos Centeno
Centro Regional de Cuidados Paliativos y Tratamiento del Dolor, Hospital Los Montalvos, Salamanca
Álvaro Sanz
Servicio de Oncologóa, Hospital Clónico Universitario, Valladolid
Eduardo Bruera
Department of Palliative and Rehabilitation Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Delirium in advanced cancer is often poorly identified and inappropriately managed. It is one of the most common causes for admission to clinical institutions and is the most frequently cited psychiatric disorder in terminal cancer. Diagnosis of delirium is defined as a disturbance of consciousness and attention with a change in cognition and/or perception. In addition, it develops suddenly and follows a fluctuating course and it is related to other causes, such as cancer, metabolic disorders or the effects of drugs. Delirium occurs in 26% to 44% of cancer patients admitted to hospital or hospice. Of all advanced cancer patients, over 80% eventually experience delirium in their final days. In advanced cancer, delirium is a multifactorial syndrome where opioids factor in almost 60% of episodes. Delirium in such patients, excluding terminal delirium, may be reversible in 50% of cases. Providing adequate end-of-life care for a patient with delirium is the main challenge. The family needs advice and it is important to create a relaxing environment for the patient. The primary therapeutic approach is to identify the reversible causes of delirium. Some therapeutic strategies have been shown to be effective: reduction or withdrawal of the psychoactive medication, opioid rotation, and hydration. Haloperidol is the most frequently used drug, and new neuroleptics such as risperidone or olanzapine are being tested with good results. Methylphenidate has been used for hypoactive delirium.
Key Words: cancer • cognition • dehydration • delirium • opioid/adverse effects • palliative care
Palliative Medicine, Vol. 18, No. 3,
184-194 (2004)
DOI: 10.1191/0269216304pm879oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
S. H. Bush and E. Bruera
The Assessment and Management of Delirium in Cancer Patients
Oncologist,
October 1, 2009;
14(10):
1039 - 1049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Maldonado
Ask the Expert: Psychosomatic Medicine/Delirium
Focus,
July 1, 2009;
7(3):
336 - 342.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Mystakidou, E Parpa, E Tsilika, C Gennatas, A Galanos, and L Vlahos
How is sleep quality affected by the psychological and symptom distress of advanced cancer patients?
Palliative Medicine,
January 1, 2009;
23(1):
46 - 53.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Kean and D. E. C. Locke
Neuropsychological Consequences of Cancer and Cancer Treatment
Neurophysiology and Neurogenic Speech and Language Disorders,
December 1, 2008;
18(4):
144 - 151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Leonard, B Raju, M Conroy, S Donnelly, P. Trzepacz, J Saunders, and D Meagher
Reversibility of delirium in terminally ill patients and predictors of mortality
Palliative Medicine,
October 1, 2008;
22(7):
848 - 854.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Irwin, C. Zurhellen, L. Diamond, L. Dunn, B. Palmer, D. Jeste, and E. Twamley
Unrecognised cognitive impairment in hospice patients: a pilot study
Palliative Medicine,
October 1, 2008;
22(7):
842 - 847.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N Jackson, J Doherty, and S Coulter
Neuropsychiatric complications of commonly used palliative care drugs
Postgrad. Med. J.,
March 1, 2008;
84(989):
121 - 126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-K. Fang, H.-W. Chen, S.-I. Liu, C.-J. Lin, L.-Y. Tsai, and Y.-L. Lai
Prevalence, Detection and Treatment of Delirium in Terminal Cancer Inpatients: A Prospective Survey
Jpn. J. Clin. Oncol.,
January 31, 2008;
(2008)
hym155v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. MEAGHER, M. MORAN, B. RAJU, D. GIBBONS, S. DONNELLY, J. SAUNDERS, and P. T. TRZEPACZ
Phenomenology of delirium: Assessment of 100 adult cases using standardised measures
The British Journal of Psychiatry,
February 1, 2007;
190(2):
135 - 141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A Spiller and J. C Keen
Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care
Palliative Medicine,
January 1, 2006;
20(1):
17 - 23.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A D (Sandy) Macleod
Psychogenic delirium?
Palliative Medicine,
March 1, 2005;
19(2):
170 - 171.
[PDF]
|
|
|
|
|
